Effects of melatonin in a place preference conditioning depend on the time of administration
|
|
- Candice Tyler
- 5 years ago
- Views:
Transcription
1 Pharmacological Reports 2010, 62, ISSN Copyright 2010 by Institute of Pharmacology Polish Academy of Sciences Effects of melatonin in a place preference conditioning depend on the time of administration Mariusz Papp, Ewa Litwa, Magdalena asoñ-tyburkiewicz, Piotr Gruca Institute of Pharmacology, Polish Academy of Sciences, Smêtna 12, PL Kraków, Poland Correspondence: Mariusz Papp, nfpapp@cyf-kr.edu.pl Abstract: A conditioned place preference paradigm was used to assess potential rewarding properties of melatonin. The conditioning with melatonin was carried out at two periods of the 12-h light/dark cycle: in the morning ( ) and in the evening ( ). Morning administration of melatonin (2.5, 5 and 10 mg/kg) did not support conditioned place preference. In contrast, evening conditioning with melatonin caused a clear shift towards the drug-paired side. This effect was dose-dependent; higher doses of 2.5, 5, 10 and 50 mg/kg induced conditioned preference while lower doses of 0.5 and 1 mg/kg were ineffective. The increase in the side preference induced by the two most effective doses of melatonin (10 and 50 mg/kg) were comparable to that induced by 1 mg/kg of amphetamine, and was significantly attenuated by the melatonin antagonist, S (20 mg/kg). In chronic experiment, melatonin (10 mg/kg) caused similar increase of the time spent on conditioned side both in animals administered vehicle for 7 days and in rats receiving 10 mg/kg of melatonin for the same period of time. Potent activity in the conditioned preference model suggests that melatonin may have rewarding properties, which moreover, is not tolerated following repeated pre-exposure to the drug. These findings may indicate potential abuse liability of melatonin, and therefore, its use by humans should require a careful monitoring for abuse and/or dependency. Key words: conditioned preference, reward, melatonin, S 22153, amphetamine, acute and repeated administration, circadian, rats Introduction Melatonin is a neurohormone that in humans as well as in animals is mainly synthesized by the pineal gland. The production and physiological activity of the melatonin system are regulated by diurnal and/or circadian rhythms, and are sensitive to light, which suppresses its activity in both diurnal and nocturnal organisms [34]. The best described physiological function of melatonin is the coordination of various biological rhythms, and therefore, the majority of animal and clinical studies with this drug concentrate on its chronobiotic or resynchronizing properties. In consequence of these studies, several therapeutic indications of melatonin have been suggested for the treatment of various circadian rhythms and sleep disorders and in some countries the use of the drug is currently quite extensive [1, 34]. In addition to chronobiotic and sleep promoting activities of melatonin, a number of other effects have been recently described in animals. For example, melatonin, as well as some of its synthetic agonists, has been reported to be active in models for anticonvulsant [8], analgesic [6, 33] and anxiolytic [9, 17, 18, 21] actions of drugs. Moreover, a clear antidepressant-like properties of melatonin has been reported in forced swim test [22] and chronic stress models [4, 20]. If all these animal activities of melatonin find confirmation in controlled clinical trials, the range of Pharmacological Reports, 2010, 62, !
2 therapeutic indications for both acute and chronic treatment with this drug may increase dramatically. This raises the problem of toxicology and adverse side-effects in patients undergoing short- and longterm melatonin therapy, and although this drug appears to be well tolerated and to produce relatively mild unwanted effects, the number of studies evaluating this problem is surprisingly small [1, 11, 14, 34]. Also in animal studies a very little attention has been paid to this issue, including the lack of any information on its putative psychomimetic properties. Therefore, the purpose of the present study was to evaluate the action of melatonin in a place preference conditioning (PPC) paradigm. This procedure is frequently used in studies on rewarding properties of psychoactive agents, and several drugs of abuse (e.g., psychostimulants, benzodiazepines, opiates, alcohol) have been shown to support the conditioned preference, while agents with little or no potential for abuse (e.g., antihistaminergic, neuroleptics) are generally inactive in this model [for review see: 5, 24, 28, 29]. The activity of various doses of melatonin in the PPC model was compared to the effect of amphetamine, a drug with known rewarding properties. According to the literature data, many, if not all, effects of melatonin in both humans and animals depends not only on the dose but also on the time of administration [see: 6 9, 34]. Therefore, in order to evaluate the role of diurnal rhythm in the action of melatonin in PPC, the drug was tested in the morning (i.e., when it is devoid of chronobiotic activity) and in the evening (see below for details). Finally, since in the clinical situation melatonin is used both acutely and chronically, the PPC study was conducted on naive animals and following 7 days of melatonin pretreatment. It was found in this study that while morning administration of melatonin was ineffective, the evening conditioning with melatonin caused a potent (i.e., comparable to that of amphetamine) conditioned place preference, and that this effect was not affected by 7 day pretreatment with the same dose of the drug. Materials and Methods Animals The experiments were carried out on male Wistar rats (Charles River, Germany) weighing g. The animals were housed in groups of 6 with food and water freely available, and were maintained on a 12-h light/dark cycle (lights on at 08.00) in a constant temperature (22 ± 2 C) and humidity (50 ± 5%) conditions. The study was conducted in compliance with the Polish Animal Protection Law of August 21, Apparatus The animals were trained and tested in ten wooden chambers containing white and black arms ( cm) with a different floor texture (plain wood or wire mash) and a grey central area ( cm). Both compartments were separated from the grey area by guillotine doors. Procedure On the first 3 days the animals were placed in the central area. After 5 s, the guillotine doors were raised and each rat was allowed freely to explore the whole chamber for 10 min. On day 4, the procedure was repeated and the time spent by animals in each part was manually recorded (through a mirror located 1.5 m above the chambers) in a 10 min pre-conditioning test. This measure was used to establish initial preference for either of the two arms of the chamber. Only those animals, which showed a clear preference for the black arm, were used for further testings. On days 5 12 the animals (n = 8 9 rats per group) were confined on alternate days for 60 min to either of the two arms (white or black), following injection of an active drug or vehicle. The drugs were injected prior to confinement to the white arm (initially non-preferred) and vehicle prior to confinement to the black arm (initially preferred). Changes in place preference were measured drug-free on day 13. The animals were again placed in the central area, after 5 s the guillotine doors were raised, and the time spend in each arm was measured manually in a 10 min post-conditioning test. As mentioned above, the conditioning with melatonin was carried out at two periods of the 12-h light/dark cycle: in the morning ( ) and in the evening ( ). In the evening experiment, an effect of melatonin antagonist, S (20 mg/kg), injected alone and in combination with melatonin, was also studied. The conditioning with amphetamine was carried out in the morning period. In a separate evening experiment, the place preference procedure was conducted as described above but the " Pharmacological Reports, 2010, 62,
3 Melatonin in place preference conditioning Mariusz Papp et al. animals were administered vehicle or 10 mg/kg of melatonin for 7 days before the conditioning. Drugs Melatonin (Sigma Aldrich) was suspended in 0.5% hydroxyethylcellulose (Merck), which was used as vehicle. D-amphetamine sulfate (Sigma Aldrich) was dissolved in distilled water. All injections were ip in a volume of 1 ml/kg body weight and were administered 30 min before confinement to the chamber. Statistics The results were analyzed by the two-way analysis of variance, with test (pre- and post-conditioning) and treatment (vehicle and drugs) as grouping variables and the time spent on conditioned side as dependent variable. The Fisher s Least Significant Difference (LSD) test was used for post-hoc comparisons of means; p values lower than 0.05 were considered statistically significant. Results The times spent on initially non-preferred side before and after evening conditioning with melatonin are shown in Figure 3. In contrast to the morning experiment, evening administration of melatonin caused a clear shift towards the drug-paired side. In consequence, when compared to vehicle injections, the overall effect of evening conditioning with melatonin led to significant effects of treatment [F(6,110) = 5.226; p < 0.001], test [F(1,110) = ; p < 0.001] and interaction [F(6,110) = 4.281; p < 0.001]. This effect was dose-dependent; high dose regimen of melatonin (2.5, 5, 10 and 50 mg/kg) was required to produce a significant increase in conditioned preference whilst the animals receiving lower doses of 0.5 and 1 mg/kg did not show any changes in place preference (Fig. 3). An increase in the side preference induced by the two most effective dose of melatonin (i.e., 10 and 50 mg/kg) were comparable to that induced by 1 mg/kg of amphetamine [F(2,23) = 0.065; NS]. The melatonin antagonist, S 22153, alone slightly and not significantly increased the post-conditioning time on the drug-paired side [test effect: F(3,28) = 1.579; NS]. However, when S was co-administered during evening acquisition of melatonin conditioned response, the shift in place preference was attenuated, resulting in a significant effects of treatment and test, In the pre-conditioning test, all animals showed a strong preference for the black side of the chamber and the times spent on the white (i.e., to-be-conditioned) side before conditioning did not differ significantly between any groups [morning exp.: F(5,43) = 0.035; NS, evening exp.: F(6,55) = 0.107; NS]. Amphetamine (1 mg/kg) administered in association with the initially non-preferred side caused a significant increase in the time spent on conditioning side in the post-conditioning test, resulting in a significant effects of treatment, test and interaction [F(1,30) = 8.317; p = 0.007, F(1,30) = 9.984; p = 0.004, F(1,30) = 8.428; p = 0.007, respectively, Fig. 1). As shown in Figure 2, morning administration of melatonin did not support conditioned place preference. This means that the times spent on initially non-preferred side following morning conditioning with any of the three doses of melatonin (2.5, 5 and 10 mg/kg) were not significantly different from those measured in the pre-conditioning test [treatment effect: F(3,56) = 0.010; NS, test effect: F(1,56) = 2.425; NS, interaction: F(3,56) = 0.013; NS]. Fig. 1. The effect of amphetamine (AMP, 1 mg/kg) on the conditioned place preference. Values are the means (± SEM) of time spent on the conditioning. *** p < 0.001; relative to pre-conditioning scores Pharmacological Reports, 2010, 62, #
4 Fig. 2. The effect of morning administration of melatonin (Mel, mg/kg) on the conditioned place preference. The drug was injected at am, i.e., two hours after the dark phase of the 12-h light/dark cycle. Values are the means (± SEM) of time spent on the conditioning Fig. 4. The effect of S22153 (S22, 20 mg/kg) on the conditioned place preference induced by melatonin (Mel, 10 mg/kg). Values are the means (± SEM) of time spent on the drug-associated side before (open bars) and after (hatched bars) conditioning. *** p < 0.001; relative to pre-conditioning scores, p < 0.001; relative to Mel alone Fig. 3. The effect of evening administration of melatonin (Mel, mg/kg) on the conditioned place preference. The drug was injected at pm, i.e., two hours before the dark phase of the 12-h light/dark cycle. Values are the means (± SEM) of time spent on the conditioning. *** p < 0.001; relative to pre-conditioning scores Fig. 5. The effect of chronic melatonin (Mel) pretreatment (10 mg/kg for 7 days) on the conditioned place preference induced by Mel (10 mg/kg). Values are the means (± SEM) of time spent on the conditioning. ** p < 0.01, *** p < 0.001; relative to pre-conditioning scores and interaction [F(1,28) = 7.457; p < 0.05, F(1,28) = ; p < 0.001, F(1,28) = 6.829; p < 0.05, Fig. 4]. In the chronic experiment (Fig. 5), melatonin (10 mg/kg) caused a similar increase of the time spent on conditioned side both in animals administered vehicle for 7 days (p = 0.003) and in rats receiving 10 mg/kg of melatonin for the same period of time (p < 0.001), leading to a significant test effect [F(1,64) = ; p < 0.001] and test treatment interaction [F(3,64) = 3.263; p < 0.05]. Discussion The PPC paradigm has been demonstrated to have high predictive validity for detecting compounds with an abuse potential in humans [5, 28, 29]. The present study shows that, in addition to a number of psychoactive drugs found active in this model, also melatonin used at doses effective in animal models of $ Pharmacological Reports, 2010, 62,
5 Melatonin in place preference conditioning Mariusz Papp et al. anxiety and depression, can increase subsequent preference for the environment in which it was administered. The magnitude of this effect is comparable to that of amphetamine, a drug with known rewarding properties. The ability of melatonin to support PPC clearly depends on the time of its administration. In other words, a shift in the conditioned preference was observed only in the evening experiment, while when injected in the morning, melatonin failed to elicit the conditioned response. This is consistent with its known chronobiotic properties in humans and with many other reports showing that most of behavioral effects of melatonin in animals show similar time-dependency. For example, in a series of elegant studies Golombek demonstrated that analgesic [6], anticonvulsant [8] and anxiolytic [9] actions of melatonin are substantially stronger if the drug was administered around the beginning of dark phase of the diurnal light/dark cycle [see also: 10]. Also in the chronic mild stress model of depression, melatonin was active only following evening administration; five weeks of its morning injections were ineffective against the stress-induced anhedonia [20]. Finally, a morning or early afternoon administrations of melatonin and other agonists of the MT1 and MT2 receptors were found inactive in the PPC paradigm as well as in other models for the preclinical abuse potential evaluation, as reported by Hirai [13] and Wiley [32]. Thus, our findings confirm that, like other behavioral activities of melatonin, its involvement in the brain reward processes is also subject to diurnal temporal regulation. The ability of melatonin to support PPC was sustained following 7 days of pretreatment, suggesting that no tolerance develops to its action in this paradigm. Also, as compared to acute experiment, the melatonin-induced PPC was not enhanced in pretreated animals, indicating that repeated administration does not cause sensitization, either. These data are in line with other reports showing that the behavioral activity of melatonin is comparable following both acute and chronic exposure to the drug [3, 15, 22, 25]. The acquisition of the melatonin-induced PPC was significantly attenuated by the MT1/MT2 receptors antagonist, S [31], confirming the involvement of these melatonin receptors in the development of this conditioned response. Similar effect was observed in the study, where S also potently antagonized the antidepressant-like activity of melatonin in the chronic mild stress model [20]. The melatonin MT1 and MT2 receptors have been cloned, identified as members of the G proteincoupled receptor family, and their localization in several brain regions was shown in a number of studies [19, 23]. Among others, melatonin receptors were identified in the mesolimbic areas (e.g., ventral tegmental area, ventral striatum), where they are colocalized with the dopaminergic neurons in both rodents and humans [30]. Although the effect of melatonin on the turnover of dopamine (DA) in nucleus accumbens and striatum is not clear [16, 36], the drug was shown to increase the affinity of D2 receptors in the rat striatum [12], providing further evidence for an intimate interaction between those two systems. Accordingly, in a number of behavioral and biochemical studies, convincing evidence were presented that melatonin can modify various behaviors controlled by the mesolimbic dopaminergic system, including locomotor and exploratory activities and emotional responses as well as that dopaminergic ligands can modify the effects of melatonin [2, 26, 35]. The above data suggest, however that melatonin inhibits, rather than potentiates, the activity of dopaminergic neurotransmission [27, 36]. Therefore, the interaction of melatonin with the mesolimbic DA system cannot explain the activity of melatonin in the PPC paradigm, suggesting an involvement of other systems. One of the candidates appears to be the benzodiazepine-gaba ) receptor complex; these receptors are also under a clear influence of melatonin and are believed to play an important role in mechanism of many of behavioral and biochemical effects of melatonin [6 8, 10, 22, 27]. Interestingly, the ligands acting at the benzodiazepine-gaba ) receptor complex have been found to share many behavioral properties of melatonin, and this includes their ability to support the place preference conditioning [28, 29]. Potent activity in the PPC model suggests that melatonin may have rewarding properties, which moreover, is not tolerated following repeated (7 days) pre-exposure to the drug. These findings may indicate abuse liability of melatonin, and therefore, its use by humans should require a careful monitoring for abuse and/or dependency. It should be, however, noted that in this study we used a biased procedure, in which animals showed strong, unconditioned preference for one side of the apparatus. Thus, in the pre-conditioning test, the rats spent substantially more time in the black Pharmacological Reports, 2010, 62, %
6 arm of the chamber (> 6 min) than in the initially non-preferred, white arm (< 2 min). Therefore, the changes in place preference induced by melatonin could alternatively be attributed to its antiaversive or antianxiety activity [see: 5, 27, 28]. This issue is particularly important for interpretation of the present results, since many reports show that melatonin is active in animal models of anxiety [9, 17, 18, 21]. In other words, the finding that melatonin supports the PPC does not necessarily mean that the drug is rewarding and as such has abuse potential; a shift of preference towards the initially non-preferred compartment could also occur through anxiolytic action of melatonin, resulting in more rapid habituation to the aversive properties of that environment. This possibility requires further studies using experimental procedures, which would allow differentiation of these two activities. References: 1. Arendt J: Importance and relevance of melatonin to human biological rhythms. J Neuroendocrinol, 2003, 15, Binfaré RW, Mantovani M, Budni J, Santos AR, Rodrigues AL: Involvement of dopamine receptors in the antidepressant-like effect of melatonin in the tail suspension test. Eur J Pharmacol, 2010, 638, Brotto LA, Barr AM, Gorzalka BB: Sex differences in forced-swim and open-field test behaviours after chronic administration of melatonin. Eur J Pharmacol, 2000, 402, Brotto LA, Gorzalka BB, LaMarre AK: Melatonin protects against the effects of chronic stress on sexual behaviour in male rats. Neuroreport, 2001, 12, Carr GF, Fibiger HC, Phillips AG: Conditioned place preference as a measure of drug reward. In: The neuropharmacological basis of reward. Eds. Liebman JM, Cooper SJ, Clarendon Press, Oxford, 1989, Golombek DA, Escolar E, Burin LJ, De Brito Sanchez MG, Cardinali DP: Time-dependent melatonin analgesia in mice: inhibition by opiate or benzodiazepine antagonism. Eur J Pharmacol, 1991, 194, Golombek DA, Escolar E, Cardinali DP: Melatonininduced depression of locomotor activity in hamsters: time-dependency and inhibition by the central-type benzodiazepine antagonist Ro Physiol Behav, 1991, 49, Golombek DA, Fernandez Duque D, De Brito Sanchez MG, Burin L, Cardinali DP: Time-dependent anticonvulsant activity of melatonin in hamsters. Eur J Pharmacol, 1992, 210, Golombek DA, Martini M, Cardinali DP: Melatonin as an anxiolytic in rats: time dependence and interaction with the central GABAergic system. Eur J Pharmacol, 1993, 237, Golombek DA, Pevet P, Cardinali DP: Melatonin effects on behavior: possible mediation by the central GABAergic system. Neurosci Biobehav Rev, 1996, 20, Guardiola-Lemaitre B: Toxicology of melatonin. J Biol Rhythms, 1997, 12, Hamdi A: Melatonin administration increases the affinity of D2 dopamine receptors in the rat striatum. Life Sci, 1998, 63, Hirai K, Kita M, Ohta H, Nishikawa H, Fujiwara Y, Ohkawa S, Miyamoto M: Ramelteon (TAK-375) accelerates reentrainment of circadian rhythm after a phase advance of the light-dark cycle in rats. J Biol Rhythms, 2005, 20, Lamberg L: Melatonin potentially useful but safety, efficacy remain uncertain. JAMA, 1996, 276, Levesque TR, Locke KW: Discriminative stimulus effects of melatonin in the rat. Psychopharmacology (Berl), 1994, 116, Millan MJ, Gobert A, Lejeune F, Dekeyne A, Newman- Tancredi A, Pasteau V, Rivet JM, Cussac D: The novel melatonin agonist agomelatine (S20098) is an antagonist at 5-hydroxytryptamine2C receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways. J Pharmacol Exp Ther, 2003, 306, Naranjo-Rodriguez EB, Osornio AO, Hernandez-Avitia E, Mendoza-Fernandez V, Escobar A: Anxiolytic-like actions of melatonin, 5-metoxytryptophol, 5-hydroxytryptophol and benzodiazepines on a conflict procedure. Prog Neuropsychopharmacol Biol Psychiatry, 2000, 24, Nava F, Carta G: Melatonin reduces anxiety induced by lipopolysaccharide in the rat. Neurosci Lett, 2001, 307, Pandi-Perumal SR, Trakht I, Srinivasan V, Spence DW, Maestroni GJ, Zisapel N, Cardinali DP: Physiological effects of melatonin: role of melatonin receptors and signal transduction pathways. Prog Neurobiol, 2008, 85, Papp M, Gruca P, Boyer P-A, Mocaër E: Effect of agomelatine in the chronic mild stress model of depression in the rat. Neuropsychopharmacology, 2003, 28, Papp M, Litwa E, Gruca P, Mocaër E: Anxiolytic-like activity of agomelatine and melatonin in three animal models of anxiety. Behav Pharmacol, 2006, 17, Raghavendra V, Kaur G, Kulkarni SK: Anti-depressant action of melatonin in chronic forced swimming-induced behavioral despair in mice, role of peripheral benzodiazepine receptor modulation. Eur Neuropsychopharmacol, 2000, 10, Reppert SM, Weaver DR, Godson C: Melatonin receptors step into the light: cloning and classification of subtypes. Trends Pharmacol Sci, 1996, 17, Sanchis-Segura C, Spanagel R: Behavioural assessment of drug reinforcement and addictive features in rodents: an overview. Addict Biol, 2006, 11, Sharma M, Gupta YK: Effect of chronic treatment of melatonin on learning, memory and oxidative deficien- & Pharmacological Reports, 2010, 62,
7 Melatonin in place preference conditioning Mariusz Papp et al. cies induced by intracerebroventricular streptozotocin in rats. Pharmacol Biochem Behav, 2001, 70, Sumaya IC, Byers DM, Irwin LN, Del Val S, Moss DE: Circadian-dependent effect of melatonin on dopaminergic D antagonist-induced hypokinesia and agonistinduced stereotypies in rats. Pharmacol Biochem Behav, 2004, 78, Tenn CC, Niles LP: Mechanisms underlying the antidopaminergic effect of clonazepam and melatonin in striatum. Neuropharmacology, 1997, 36, Tzschentke TM: Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues. Prog Neurobiol, 1998, 56, Tzschentke TM: Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade. Addict Biol, 2007, 12, Uz TT, Arslan AD, Kurtuneu M, Imbesi M, Akhisaroglu M, Dwivedi Y, Pandey GN, Manev H: The regional and cellular expression profile of the melatonin receptor MT1 in the central dopaminergic system. Mol Brain Res, 2005; 136: Weibel L, Rettori MC, Lesieur D, Delagrange P, Renard P, Van Reeth O: A single oral dose of S 22153, a melatonin antagonist, blocks the phase advancing effects of melatonin in C3H mice. Brain Res, 1999, 829, Wiley JL, Dance ME, Balster RL: Preclinical evaluation of the reinforcing and discriminative stimulus effects of agomelatine (S-20098), a melatonin agonist. Psychopharmacology (Berl), 1998, 140, Yu CX, Zhu CB, Xu SF, Cao XD, Wu GC: Selective MT melatonin receptor antagonist blocks melatonininduced antinociception in rats. Neurosci Lett, 2000, 282, Zawilska JB, Nowak JZ: Melatonin: from biochemistry to therapeutic applications. Pol J Pharmacol, 1999, 51, Zhdanova IV, Giorgetti M: Melatonin alters behavior and camp levels in nucleus accumbens induced by cocaine treatment. Brain Res, 2002, 956, Zisapel N: Melatonin-dopamine interactions: from basic neurochemistry to a clinical setting. Cell Mol Neurobiol, 2001, 21, Received: July 12, 2010; in revised form: September 17, Pharmacological Reports, 2010, 62, '
Adolescent Prozac Exposure Enhances Sensitivity to Cocaine in Adulthood INTRODUCTION
INTRODUCTION Epidemiologic reports indicate that mood disorders in children and adolescents are quite common, with up to 70% of depressed children and adolescents experiencing a recurrence within 5 years
More informationRepeated stress exposure causes strain-dependent shifts in the behavioral economics of cocaine in rats
bs_bs_banneraddiction Biology PRECLINICAL STUDY doi:10.1111/adb.12123 Repeated stress exposure causes strain-dependent shifts in the behavioral economics of cocaine in rats Peter A. Groblewski 1, Chad
More informationRecent Advances in Energy, Environment, Biology and Ecology
Acute and long-term effects elicited by psychoactive drugs on 50-kHz ultrasonic vocalizations in rats: development of a new experimental tool for the study of drug-mediated reward NICOLA SIMOLA Department
More informationStudy of Agomelatine for the Reduction of Marble Buying Behavior in Brain Disorder
Research Article Study of Agomelatine for the Reduction of Marble Buying Behavior in Brain Disorder Shaily Chaudhary* 1,2 Akash Yadav 3 Nikunjana Patel 4 Indrajeet Singhvi 1 1Faculty of Pharmacy, Pacific
More informationEffects of Alprazolam and Fluoxetine on Morphine Sensitization in Mice
Physiol. Res. 51: 417-423, 2002 Effects of Alprazolam and Fluoxetine on Sensitization in Mice M. VOTAVA, M. KRŠIAK, V. MORAVEC Department of Pharmacology, Third Faculty of Medicine, Charles University,
More informationProtective Effect of Mentat (BR-16A) A Herbal Preparation, on Alcohol Abstinence-Induced Anxiety and Convulsions
[Indian Journal of Experimental Biology (1993): (31), 435] Protective Effect of Mentat (BR-16A) A Herbal Preparation, on Alcohol Abstinence-Induced Anxiety and Convulsions Kulkarni, S.K. and Anita Verma,
More informationLOW DOSE OF ETHANOL INDUCES CONDITIONED PLACE PREFERENCE IN RATS AFTER REPEATED EXPOSURES TO ETHANOL OR SALINE INJECTIONS
Alcohol < Alcoholism Vol. 31, No. 6, pp. 547-553, 1996 LOW DOSE OF ETHANOL INDUCES CONDITIONED PLACE PREFERENCE IN RATS AFTER REPEATED EXPOSURES TO ETHANOL OR SALINE INJECTIONS PRZEMYSLAW BIENKOWSKI 12,
More informationMOLECULAR BIOLOGY OF DRUG ADDICTION. Sylvane Desrivières, SGDP Centre
1 MOLECULAR BIOLOGY OF DRUG ADDICTION Sylvane Desrivières, SGDP Centre Reward 2 Humans, as well as other organisms engage in behaviours that are rewarding The pleasurable feelings provide positive reinforcement
More informationAbstract. Introduction. R.N. Takahashi 1, O. Berton 2,3, P. Mormède 2 and F. Chaouloff 2
Brazilian Journal of Medical and Biological Research (21) 34: 675-682 Effects of diazepam and SB 26553 in SHR and Lewis rats ISSN 1-879X 675 Strain-dependent effects of diazepam and the 5-HT 2B/2C receptor
More informationTianeptine Dependence: A Case Report
CASE REPORT Tianeptine Dependence: A Case Report Syed Nabil, Ng Chong Guan, Rusdi Abd Rashid Department of Psychological Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia Abstract
More informationMethamphetamine-Induced Conditioned Place Preference In Adolescent Male and Female Mice of Two Strains
City University of New York (CUNY) CUNY Academic Works School of Arts & Sciences Theses Hunter College Summer 8-10-2017 Methamphetamine-Induced Conditioned Place Preference In Adolescent Male and Female
More informationUltra-low-dose naltrexone suppresses rewarding effects of opiates and aversive effects of opiate withdrawal in rats
Psychopharmacology (2005) 181: 576 581 DOI 10.1007/s00213-005-0022-7 ORIGINAL INVESTIGATION Mary C. Olmstead. Lindsay H. Burns Ultra-low-dose naltrexone suppresses rewarding effects of opiates and aversive
More informationATTENUATION OF STRESS-INDUCED BEHAVIORAL DEFICITS BY AZADIRACHTA INDICA (NEEM): ROLE OF SEROTONIN
Pak. J. Bot., 38(1): 131-138, 26. ATTENUATION OF STRESS-INDUCED BEHAVIORAL DEFICITS BY AZADIRACHTA INDICA (NEEM): ROLE OF SEROTONIN NOREEN SAMAD, TAHIRA PARVEEN, SAIDA HAIDER AND DARAKHSHAN JABEEN HALEEM
More informationNo! No! No! No! With the possible exception of humans Public Health Question Does the compound have the potential to be abused? Public Health Question Does the compound have the potential to be abused?
More informationSHORT COMMUNICATION EFFECT OF SILDENAFIL ON ANXIETY IN THE PLUS-MAZE TEST IN MICE
Copyright 2004 by Institute of Pharmacology Polish Academy of Sciences Polish Journal of Pharmacology Pol. J. Pharmacol., 2004, 56, 353 357 ISSN 1230-6002 SHORT COMMUNICATION EFFECT OF SILDENAFIL ON ANXIETY
More informationMelatonin protects against the effects of chronic stress on sexual behaviour in male rats
MOTIVATION, EMOTION, FEEDING, DRINKING Melatonin protects against the effects of chronic stress on sexual behaviour in male rats Lori A. Brotto, Boris B. Gorzalka CA and Amanda K. LaMarre Department of
More informationMeCP2 and psychostimulantinduced behavioral adaptations. Anne E. West, M.D., Ph.D. Department of Neurobiology Duke University Medical Center
MeCP2 and psychostimulantinduced behavioral adaptations Anne E. West, M.D., Ph.D. Department of Neurobiology Duke University Medical Center Psychostimulants and antidepressants slowly change behavior Psychostimulants
More informationEVALUATION OF ANTIDEPRESSANT ACTIVITY OF ONDANSETRON IN ALBINO MICE
EVALUATION OF ANTIDEPRESSANT ACTIVITY OF ONDANSETRON IN ALBINO MICE *Janardhan M. 1, Anil kumar G. 1 and Naveen Kumar T. 2 1 Department of Pharmacology, Kamineni Institute of Medical Sciences and Research,
More informationInsights into the Neural Bases of Addiction. Anthony Phillips University of British Columbia Institute of Mental Health
Insights into the Neural Bases of Addiction Anthony Phillips University of British Columbia Institute of Mental Health Drug addiction is a brain disease with the following cardinal features: Compulsive
More informationEffect of co-treatment with mirtazapine and risperidone in animal models of the positive symptoms of schizophrenia in mice
Pharmacological Reports 2012, 64, 1567 1572 ISSN 1734-1140 Copyright 2012 by Institute of Pharmacology Polish Academy of Sciences Short communication Effect of co-treatment with mirtazapine and risperidone
More informationD. Nishizawa 1, N. Gajya 2 and K. Ikeda 1, * Global Research & Development, Nagoya Laboratories, Pfizer Japan Inc, Nagoya, Japan
Current Neuropharmacology, 2011, 9, 113-117 113 Identification of Selective Agonists and Antagonists to G Protein-Activated Inwardly Rectifying Potassium Channels: Candidate Medicines for Drug Dependence
More informationEffects of bupropion on the reinstatement of nicotine-induced conditioned place preference by drug priming in rats
Pharmacological Reports 2011, 63, 362 371 ISSN 1734-1140 Copyright 2011 by Institute of Pharmacology Polish Academy of Sciences Effects of bupropion on the reinstatement of nicotine-induced conditioned
More informationJournal of Chemical and Pharmaceutical Research
Available online www.jocpr.com Journal of Chemical and Pharmaceutical Research ISSN No: 0975-7384 CODEN(USA): JCPRC5 J. Chem. Pharm. Res., 2011, 3(5):468-472 Study on the anticonvulsant activity of Pentazocine
More informationDrugs, The Brain, and Behavior
Drugs, The Brain, and Behavior John Nyby Department of Biological Sciences Lehigh University What is a drug? Difficult to define Know it when you see it Neuroactive vs Non-Neuroactive drugs Two major types
More informationThe role of beta-endorphin in the acute motor stimulatory and rewarding actions of cocaine in mice
Psychopharmacology (2008) 197:443 448 DOI 10.1007/s00213-007-1053-z ORIGINAL INVESTIGATION The role of beta-endorphin in the acute motor stimulatory and rewarding actions of cocaine in mice Paul Marquez
More informationTRAMADOL, A CENTRALLY ACTING OPIOID : ANTICONVULSANT EFFECT AGAINST MAXIMAL ELECTROSHOCK SEIZURE IN MICE
Indian J Physiol Pharmacol 1998; 42 (3) : 407-411 TRAMADOL, A CENTRALLY ACTING OPIOID : ANTICONVULSANT EFFECT AGAINST MAXIMAL ELECTROSHOCK SEIZURE IN MICE ANSHU MANOCHA, KRISHNA K. SHARMA* AND PRAMOD K.
More informationPsychoactive Drugs & The Brain
Psychoactive Drugs & The Brain Psychoactive Substances & The Brain 1. Psychoactive substances enter the bloodstream via oral administration, inhalation, smoking, or injection 2. Psychoactive substances
More informationDRUGS THAT ACT IN THE CNS
DRUGS THAT ACT IN THE CNS Anxiolytic and Hypnotic Drugs Dr Karamallah S. Mahmood PhD Clinical Pharmacology 1 OTHER ANXIOLYTIC AGENTS/ A. Antidepressants Many antidepressants are effective in the treatment
More informationThe study of drugs. Pharmacology
The study of drugs Pharmacology Psychopharmacology The study of psychoactive drugs Psychoactive drugs Drugs that influence psychological processes mood emotion perception cognition behavior Psychoactive
More informationSupplementary Online Content
Supplementary Online Content Xue Y-X, Deng J-H, Chen Y-Y, et al. Effect of selective inhibition of reactivated nicotineassociated memories with propranolol on nicotine craving. JAMA Psychiatry. Published
More informationEFFECTS OF CHLOROGENIC ACID ON LEARNING AND MEMORY IN RATS
Trakia Journal of Sciences, Vol. 12, Suppl. 1, pp 132-136, 2014 Copyright 2014 Trakia University Available online at: http://www.uni-sz.bg ISSN 1313-7050 (print) ISSN 1313-3551 (online) EFFECTS OF CHLOROGENIC
More informationPRESENTER: DR. DEEPA JJM MEDICAL COLLEGE DAVANGERE
PRESENTER: DR. DEEPA JJM MEDICAL COLLEGE DAVANGERE Depression is a most common mood disorders characterised by a feeling of worthlessness, sadness and suicidal thoughts. Affects more than 10-15% of the
More informationEffects of a Novel Fentanyl Derivative on Drug Discrimination and Learning in Rhesus Monkeys
PII S0091-3057(99)00058-1 Pharmacology Biochemistry and Behavior, Vol. 64, No. 2, pp. 367 371, 1999 1999 Elsevier Science Inc. Printed in the USA. All rights reserved 0091-3057/99/$ see front matter Effects
More informationAM281, Cannabinoid Antagonist/Inverse agonist, Ameliorates Scopolamine- Induced Cognitive Deficit
Iranian Journal of Basic Medical Sciences Vol. 15, No. 5, Sep-Oct 2012, 1106-1110 Received: May 28, 2011; Accepted: Dec 24, 2011 www.mums.ac.ir Short Communication AM281, Cannabinoid Antagonist/Inverse
More informationMk-801 Administration in Adolescent Male Rats and Cocaine Conditioned Place
Mk-801 Administration in Adolescent Male Rats and Cocaine Conditioned Place Preference Stephanie Willis, Jonnique Adjmul, Shabaaz Sandhu, Antoniette M. Maldonado-Devincci, Cheryl Kirsten ABSTRACT The present
More informationSHORT COMMUNICATION RISE IN ZINC AFFINITY FOR THE NMDA RECEPTOR EVOKED BY CHRONIC IMIPRAMINE IS SPECIES-SPECIFIC
Copyright 2001 by Institute of Pharmacology Polish Academy of Sciences Polish Journal of Pharmacology Pol. J. Pharmacol., 2001, 53, 641 645 ISSN 1230-6002 SHORT COMMUNICATION RISE IN ZINC AFFINITY FOR
More informationBRAIN MECHANISMS OF REWARD AND ADDICTION
BRAIN MECHANISMS OF REWARD AND ADDICTION TREVOR.W. ROBBINS Department of Experimental Psychology, University of Cambridge Many drugs of abuse, including stimulants such as amphetamine and cocaine, opiates
More informationDoes nicotine alter what is learned about non-drug incentives?
East Tennessee State University Digital Commons @ East Tennessee State University Undergraduate Honors Theses 5-2014 Does nicotine alter what is learned about non-drug incentives? Tarra L. Baker Follow
More informationNeurotransmitter Functioning In Major Depressive Disorder
Neurotransmitter Functioning In Major Depressive Disorder Otsuka Pharmaceutical Development & Commercialization, Inc. 2017 Otsuka Pharmaceutical Development & Commercialization, Inc., Rockville, MD January
More informationContrasting effects of acute and chronic treatments with ketamine on inhibitory avoidance and escape latency in the elevated-t-maze
Available online at http://ajol.info/index.php/ijbcs Int. J. Biol. Chem. Sci. 8(6): 2387-2394, December 2014 ISSN 1997-342X (Online), ISSN 1991-8631 (Print) Original Paper http://indexmedicus.afro.who.int
More informationVASILE HEFCO 1*, LUCIAN HRITCU 1, ADRIAN TIRON 1, ANDREEA-IOANA HEFCO 1
THE EFFECTS OF NICOTINIC TREATMENT ON MEMORY AND LEARNING IMPAIRMENT INDUCED BY BLOCKADE OF MUSCARINIC ACETYLCHOLINE RECEPTORS ON PERFORMANCE IN RADIAL ARM-MAZE TASK IN RATS VASILE HEFCO, LUCIAN HRITCU,
More informationLESIONS OF THE MESOLIMBIC DOPAMINE SYSTEM DISRUPT SIGNALLED ESCAPE RESPONSES IN THE RAT
ACTA NEUROBIOL: EXP. 1988, 48: 117-121 Short communication LESIONS OF THE MESOLIMBIC DOPAMINE SYSTEM DISRUPT SIGNALLED ESCAPE RESPONSES IN THE RAT W. Jeffrey WILSON and Jennifer C. HALL Department of Psychological
More informationAN EXPERIMENTAL MODEL OF ALCOHOL-INDUCED ANXIETY AND DEPRESSIVE BEHAVIOUR IN RATS
ORIGINAL ARTICLES AN EXPERIMENTAL MODEL OF ALCOHOL-INDUCED ANXIETY AND DEPRESSIVE BEHAVIOUR IN RATS Stefka Valcheva-Kuzmanova 1, Miroslav Eftimov 1, Krasimir Kuzmanov 2 ABSTRACT 1 Department of Preclinical
More informationPsychotropic Drugs in the Pipeline. Norman Sussman, M.D. Professor of Psychiatry New York University School of Medicine
Psychotropic Drugs in the Pipeline Norman Sussman, M.D. Professor of Psychiatry New York University School of Medicine Norman Sussman, MD No Conflict of Interest to Declare Antidepressant Pipeline We need
More informationEmotion I: General concepts, fear and anxiety
C82NAB Neuroscience and Behaviour Emotion I: General concepts, fear and anxiety Tobias Bast, School of Psychology, University of Nottingham 1 Outline Emotion I (first part) Studying brain substrates of
More informationEffect of combined treatment with mirtazapine and risperidone on the MK-801-induced changes in the object recognition test in mice
Pharmacological Reports 2013, 65, 1401 1406 ISSN 1734-1140 Copyright 2013 by Institute of Pharmacology Polish Academy of Sciences Short communication Effect of combined treatment with mirtazapine and risperidone
More informationUnderstanding Addiction and Its Impact on the Brain. SDSMA Webinar Matthew Stanley, DO
Understanding Addiction and Its Impact on the Brain SDSMA Webinar Matthew Stanley, DO Estimated Economic Cost to Society Due to Substance Abuse and Addiction: Illegal drugs: Alcohol: Tobacco: $181 billion/year
More informationThe role of β-phenylethylamine in behavioral sensitization
The role of β-phenylethylamine in behavioral sensitization Hye Kyoung Park Department of Medical Science The Graduate School, Yonsei University The role of β-phenylethylamine in behavioral sensitization
More informationNIH Public Access Author Manuscript Nat Neurosci. Author manuscript; available in PMC 2006 September 5.
NIH Public Access Author Manuscript Published in final edited form as: Nat Neurosci. 2006 August ; 9(8): 1004 1006. Maternal presence serves as a switch between learning fear and attraction in infancy
More informationEffect of Withania somnifera Dunal in ethanol-induced anxiolysis and withdrawal anxiety in rats
Indian Journal of Experimental Biology Vol. 46, June 2008, pp. 470-475 Effect of Withania somnifera Dunal in ethanol-induced anxiolysis and withdrawal anxiety in rats Girdhari Lal Gupta & Avtar Chand Rana
More informationNitric oxide (NO) and central dopamine (DA) D3 receptor reactivity to quinpirole in rats
Nitric oxide (NO) and central dopamine (DA) D3 receptor reactivity to quinpirole in rats Ryszard ~rusl, Ryszard szkilnik1 and Richard M. ~ostrzewa~ '~e~artment of Pharmacology, Silesian Academy of Medicine,
More informationAberrant approach-avoidance conflict resolution following repeated cocaine pre-exposure
DOI 10.1007/s00213-015-4006-y ORIGINAL INVESTIGATION Aberrant approach-avoidance conflict resolution following repeated cocaine pre-exposure David Nguyen 1 & Anett Schumacher 1 & Suzanne Erb 1 & Rutsuko
More informationSleep and Melatonin in Diurnal Species
CHAPTER 17 Sleep and Melatonin in Diurnal Species Irina V. Zhdanova Abstract Melatonin secretion, occurring at night in both diurnal and nocturnal species, provides an important circadian signal for initiating
More informationReference place conditioning procedure with cocaine: Increased sensitivity for measuring associatively motivated choice behavior in rats
University of Nebraska - Lincoln DigitalCommons@University of Nebraska - Lincoln Faculty Publications, Department of Psychology Psychology, Department of 2010 Reference place conditioning procedure with
More informationHow to measure rodent behavior and perform a neurological screen.
An Organ Systems Approach to Experimental Targeting of the Metabolic Syndrome How to measure rodent behavior and perform a neurological screen. Fiona Harrison, PhD Department of Medicine Vanderbilt University
More informationThe future of pharmacological treatment.
The future of pharmacological treatment. Anne Lingford-Hughes Professor of Addiction Biology, Imperial College. Hon Consultant CNWL NHS Foundation Trust. What substances and when? What Nicotine Alcohol
More informationEffects of Systemic Administration of 8-OH-DPAT on Agonistic Social Behaviors in Male Syrian Hamsters
Georgia State University ScholarWorks @ Georgia State University Neuroscience Honors Theses Neuroscience Institute Spring 5-5-2017 Effects of Systemic Administration of 8-OH-DPAT on Agonistic Social Behaviors
More informationDopaminergic Signaling Mediates the Motivational Response Underlying the Opponent Process to Chronic but Not Acute Nicotine
(21) 35, 943 954 & 21 Nature Publishing Group All rights reserved 893-133X/1 $32. www.neuropsychopharmacology.org Dopaminergic Signaling Mediates the Motivational Response Underlying the Opponent Process
More informationThe effects of environmental enrichment on nicotine sensitization in a rodent model of schizophrenia
East Tennessee State University Digital Commons @ East Tennessee State University Undergraduate Honors Theses 5-2014 The effects of environmental enrichment on nicotine sensitization in a rodent model
More informationGhrelin mediates stressinduced. behavior in mice. Chuang et al 2011 L3: Love, Lust, Labor
Ghrelin mediates stressinduced food-reward behavior in mice Chuang et al 2011 L3: Love, Lust, Labor Agenda Introduction What is Ghrelin? Previous Models New model Methods Results Discussion Conclusion
More informationUCLA International Journal of Comparative Psychology
UCLA International Journal of Comparative Psychology Title Inhibition of Successive Positive Contrast in Rats Withdrawn from an Escalating Dose Schedule of D-amphetamine Permalink https://escholarship.org/uc/item/8f42w3bg
More informationC81ADD Psychology of Addiction. Alcohol. Ethyl alcohol (ethanol) School of Psychology. Tobias Bast.
C81ADD Psychology of Addiction Alcohol Ethyl alcohol (ethanol) Tobias Bast School of Psychology tobias.bast@nottingham.ac.uk 1 Outline Relevance of alcohol to individual and society: alcohol-associated
More informationNeuropharmacodynamic Profile of NKTR-181: Correlation to Low Abuse Potential
Neuropharmacodynamic Profile of NKTR-181: Correlation to Low Abuse Potential Laurie VanderVeen, Takahiro Miyazaki, Irene Choi, Michael A. Eldon, Xue Snow Ge, Hema Gursahani, Faye Hsieh, Aleksandrs Odinecs,
More informationMethamphetamine-induced Conditioned Place Preference is Facilitated by Estradiol Pretreatment in Female Mice
Chinese Journal of Physiology 46(4): 169-174, 3 169 Methamphetamine-induced Conditioned Place Preference is Facilitated by Estradiol Pretreatment in Female Mice H-H. Chen 1, Y-K. Yang 2, T-L. Yeh 2, C-F.
More informationRimonabant for treating tobacco dependence
REVIEW Rimonabant for treating tobacco dependence Michael B Steinberg 1,2 Jonathan Foulds 1 1 University of Medicine and Dentistry of New Jersey School of Public Health, Tobacco Dependence Program, New
More informationA single cocaine exposure enhances both opioid reward and aversion through a ventral tegmental area-dependent mechanism
A single cocaine exposure enhances both opioid reward and aversion through a ventral tegmental area-dependent mechanism Joseph A. Kim, Kelly A. Pollak, Gregory O. Hjelmstad, and Howard L. Fields* Ernest
More information"One-trial tolerance" to the anxiolytic actions of benzodiazepines in the elevated plus-maze, or the development of a phobic state?
Psychopharmacology (1993) 11:24-244 Psychopharmacology Springer-Verlag 1993 "One-trial tolerance" to the anxiolytic actions of benzodiazepines in the elevated plus-maze, or the development of a phobic
More informationA Benefit-Risk Assessment of Agomelatine in the Treatment of Major Depression
REVIEW ARTICLE Drug Saf 2011; 34 (9): 709-731 0114-5916/11/0009-0709/$49.95/0 ª 2011 Adis Data Information BV. All rights reserved. A Benefit-Risk Assessment of Agomelatine in the Treatment of Major Depression
More informationReflections On The Development Of Glutamate-Based Antidepressants
Reflections On The Development Of Glutamate-Based Antidepressants Phil Skolnick, Ph.D., D.Sc. (hon.) Chief Scientific Officer ASCP, May 2018 1 Conflict of Interest I am a full time of employee of Opiant
More informationSUPPLEMENTARY INFORMATION
doi:10.1038/nature11436 Supplementary Figure 1. CRF peptide is localized cholinergic interneurons throughout the nucleus accumbens. Immunofluorescent images demonstrating localization of CRF peptide, tyrosine
More informationAlcohol: Its effects on the brain and implications for future treatment. Dr Mark Daglish
Alcohol: Its effects on the brain and implications for future treatment Senior Lecturer in Addiction Psychiatry University of Queensland Dr Mark Daglish Director of Addiction Psychiatry Royal Brisbane
More informationEffects of lesions of the nucleus accumbens core and shell on response-specific Pavlovian i n s t ru mental transfer
Effects of lesions of the nucleus accumbens core and shell on response-specific Pavlovian i n s t ru mental transfer RN Cardinal, JA Parkinson *, TW Robbins, A Dickinson, BJ Everitt Departments of Experimental
More information^ PRIMER OF DRUG ACTION A comprehensive gyide to the actions, uses, and side effects of psychoactive drugs
^ PRIMER OF DRUG ACTION A comprehensive gyide to the actions, uses, and side effects of psychoactive drugs wm, ROBERT M.JULIEN M.D.. PH.D. Claire D. Advokat, Ph.D. Louisiana State University and Joseph
More informationAmerica is a drugged society
Overview of Drug Abuse Basic Considerations. M. Imad Damaj, Ph.D. Associate Professor Dept. of Pharmacology/Toxicology, Virginia Commonwealth University America is a drugged society 90% of all drugs manufactured
More informationInhibition of the Acquisition of Conditioned Place Aversion by Dopaminergic Lesions of the Central Nucleus of the Amygdala in Morphine-Treated Rats
Physiol. Res. 61: 437-442, 2012 RAPID COMMUNICATION Inhibition of the Acquisition of Conditioned Place Aversion by Dopaminergic Lesions of the Central Nucleus of the Amygdala in Morphine-Treated Rats W.
More informationDOES THE D 3 DOPAMINE RECEPTOR (D 3 r)play A ROLE IN ADDICTION? Isabelle Boileau, PhD
DOES THE D 3 DOPAMINE RECEPTOR (D 3 r)play A ROLE IN ADDICTION? Isabelle Boileau, PhD Acknowledgments Human Neurochemical Pathology Lab Stephen J. Kish, PhD Jun Chao Tong, PhD Centre for Movement Disorders
More informationEXTERNAL AND INTERNAL STIMULI have signaling
The dopamine hypothesis of reward: past and current status Rainer Spanagel and Friedbert Weiss R. Spanagel and F. Weiss Dopamine and reward R EVIEW Mesolimbic dopaminergic neurons are thought to serve
More informationRhodiola rosea L- Standardized Extract on Passive
Research Article ISSN: 0976-5700 Rhodiola rosea L- Standardized Extract on Passive Avoidance in Rats Liliya Vl Vasileva 1,2,3*, Damyanka P Getova 3 1Department of Pharmacology and Clinical Pharmacology,
More informationANTAGONISM OF APOMORPHINE-INDUCED CAGE CLIMBING BEHAVIOUR AND METHAMPHETAMINE STEREOTYPY BY FENFLURAMINE IN MICE
SHORT COMMUNICATION ANTAGONISM OF APOMORPHINE-INDUCED CAGE CLIMBING BEHAVIOUR AND METHAMPHETAMINE STEREOTYPY BY FENFLURAMINE IN MICE V. P. GADA. V. V. JOSHI. J. J. BALSARA AND A. G. CHANDORKAR Department
More informationInvolvement of NMDA and AMPA receptors in the antidepressant-like activity of antidepressant drugs in the forced swim test
Pharmacological Reports 2013, 65, 991 997 ISSN 1734-1140 Copyright 2013 by Institute of Pharmacology Polish Academy of Sciences Short communication Involvement of NMDA and AMPA receptors in the antidepressant-like
More informationNovel Compounds for Treatment of Alcohol Addiction and Anxiety
Novel Compounds for Treatment of Alcohol Addiction and Anxiety (OTT ID 1147) Inventors: James Cook, Ph.D.; Michael Van Linn, Ph.D.; Wenyuan Yin, Ph.D. Department of Chemistry and Biochemistry UW-Milwaukee
More informationThe Effects of Clozapine on Methylphenidate-Induced Conditioned Place Preference Tiffany Wilkins, a Robin McGovern a
The Effects of Clozapine on Methylphenidate-Induced Conditioned Place Preference Tiffany Wilkins, a Robin McGovern a Methylphenidate (MPH) is commonly prescribed for attention deficit/hyperactivity disorder
More informationTomek J. Banasikowski. A thesis submitted to the Centre for Neuroscience Studies. In conformity with the requirements for
DOUBLE DISSOCIATION OF THE EFFECTS OF HALOPERIDOL AND THE DOPAMINE D3 RECEPTOR-SPECIFIC ANTAGONIST ABT-127 ON ACQUISITION VS. EXPRESSION OF COCAINE CONDITIONED ACTIVITY by Tomek J. Banasikowski A thesis
More informationDifferential sensitivity to the acute and sensitizing behavioral effects of methylphenidate as a function of strain in adolescent and young adult rats
Yetnikoff and Arvanitogiannis Behavioral and Brain Functions 2013, 9:38 SHORT PAPER Open Access Differential sensitivity to the acute and sensitizing behavioral effects of methylphenidate as a function
More informationDrugs for psychosis and mood: unique actions at D3, D2, and D1 dopamine receptor subtypes
CNS Spectrums (2017), 22, 375 384. Cambridge University Press 2017 doi:10.1017/s1092852917000608 Drugs for psychosis and mood: unique actions at,, and dopamine receptor subtypes Stephen M. Stahl ISSUE:
More informationPrevention of Development of Tolerance and Dependence to Opiate in Mice by BR-16A (Mentat) A Herbal Psychotropic Preparation
[Indian Journal of Experimental Biology (1992): (30), 885] Prevention of Development of Tolerance and Dependence to Opiate in Mice by BR-16A (Mentat) A Herbal Psychotropic Preparation Kulkarni, S.K. and
More informationPN6047; a potent and. selective delta opioid receptor agonist, effective against chronic pain
PN6047; a potent and selective delta opioid receptor agonist, effective against chronic pain Therapeutic target Chronic pain varies from mild discomfort to the worst pain imaginable. In the UK, the total
More informationINTRODUCTION. Ninglei Sun 1, Steven R Laviolette*,1,2,3 and Addiction Research Group
(2014) 39, 2799 2815 & 2014 American College of. All rights reserved 0893-133X/14 www.neuropsychopharmacology.org Dopamine Receptor Blockade Modulates the Rewarding and Aversive Properties of Nicotine
More informationA. Personal Statement
NAME: CHARTOFF, ELENA OMB No. 0925-0001 and 0925-0002 (Rev. 10/15 Approved Through 10/31/2018) BIOGRAPHICAL SKETCH Provide the following information for the Senior/key personnel and other significant contributors.
More informationMELATONIN RECEPTOR KNOCKOUT MICE HAVE AN INCREASED PHYSIOLOGICAL REACTION TO NICOTINE AND INCREASED VOLUNTARY ORAL NICOTINE CONSUMPTION.
MELATONIN RECEPTOR KNOCKOUT MICE HAVE AN INCREASED PHYSIOLOGICAL REACTION TO NICOTINE AND INCREASED VOLUNTARY ORAL NICOTINE CONSUMPTION. by Sheila Irene Bridget Maier A thesis submitted to the Faculty
More informationUniversity of Groningen
University of Groningen S20098 affects the free-running rhythms of body temperature and activity and decreases light-induced phase delays of circadian rhythms of the rat Tuma, J; Strubbe, JH; Mocaer, E;
More informationPsychoactive drugs Drugs which affect mental processes. Legal but restricted (by prescription only)
Psychoactive drugs Drugs which affect mental processes mood, perception, memory, state of consciousness May be illegal: Heroin Cocaine Legal: Alcohol nicotine Legal but restricted (by prescription only)
More informationEvidence for Nootropic Effect of BR-16A (Mentat), A Herbal Psychotropic Preparation, in Mice
[Indian Journal of Physiology and Pharmacology (1992): 36 (1), 29] Evidence for Nootropic Effect of BR-16A (), A Herbal Psychotropic Preparation, in Mice Kulkarni, S.K. and Anita Verma Department of Pharmaceutical
More informationBASIC VOLUME. Elements of Drug Dependence Treatment
BASIC VOLUME Elements of Drug Dependence Treatment Module 3 Principles of CBT and relapse prevention strategies Introduction to Cognitive Behavioural Therapy Basics of pharmacological treatment Workshop
More informationCholinergic influence on memory stages: A study on scopolamine amnesic mice
Research Article Cholinergic influence on memory stages: A study on scopolamine amnesic mice Rahul Agrawal, Ethika Tyagi, Gunjan Saxena, Chandishwar Nath 1 ABSTRACT Division of Pharmacology, 1 Division
More informationRimonabant attenuates sensitization, crosssensitization and cross-reinstatement of place preference induced by nicotine and ethanol
Pharmacological Reports 2010, 62, 797 807 ISSN 1734-1140 Copyright 2010 by Institute of Pharmacology Polish Academy of Sciences attenuates sensitization, crosssensitization and cross-reinstatement of place
More informationEffect of MS-153, a glutamate transporter activator, on the conditioned rewarding effects of morphine, methamphetamine and cocaine in mice
Behavioural Brain Research 156 (2005) 233 239 Research report Effect of MS-153, a glutamate transporter activator, on the conditioned rewarding effects of morphine, methamphetamine and cocaine in mice
More informationEfficacy and the discriminative stimulus effects of negative GABA A modulators, or inverse
JPET This Fast article Forward. has not been Published copyedited and on formatted. May 16, The 26 final as version DOI:1.1124/jpet.16.13168 may differ from this version. Efficacy and the discriminative
More informationSubconvulsive Dose of Kainic Acid Transiently Increases the Locomotor Activity of Adult Wistar Rats
Physiol. Res. 64: 263-267, 2015 SHORT COMMUNICATION Subconvulsive Dose of Kainic Acid Transiently Increases the Locomotor Activity of Adult Wistar Rats V. RILJAK 1, D. MAREŠOVÁ 1, J. POKORNÝ 1, K. JANDOVÁ
More informationAntagonism of the discriminative stimulus properties of cocaine with the combination of a dopamine Dl and D2 antagonist
Antagonism of the discriminative stimulus properties of cocaine with the combination of a dopamine Dl and D2 antagonist Theo F. Meert, Patrick De Haes, Nancy Aerts and Gilbert Clincke Department of Neuropsychopharmacology,
More information